Evidence map›Paper›PMID 25162662›Full record

ArticlePloS one2014

Genome-wide association study identifies variants in PMS1 associated with serum ferritin in a Chinese population.

Ming Liao, Jianying Shi, Lirong Huang, Yong Gao, Aihua Tan, Chunlei Wu, Zheng Lu, Xiaobo Yang, Shijun Zhang, Yanlin Hu and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Ethnic Differences in Iron Status.Advances in nutrition (Bethesda, Md.) · 2021
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Ming LiaoInstitute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China; Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China.
Jianying ShiCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China.
Lirong HuangCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China.
Yong GaoCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China.
Aihua TanCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China.
Chunlei WuCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China; Urology Department, First Affiliated Hospital of Xinxiang Medical College, Xinxiang, Henan Province, China.
Zheng LuInstitute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China; Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China.
Xiaobo YangCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China; School of Public Health, Guangxi Medical University, Nanning, Guangxi, PR China.
Shijun ZhangCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China; Department of Pharmacology, Guangxi Medical University, Nanning, Guangxi, PR China.
Yanlin HuCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China; Medical Scientific Research Center, Guangxi Medical University, Nanning, Guangxi, PR China.
Xue QinCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China; Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.
Jianling LiCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China; Institute of Cardiovascular Disease, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.
Gang ChenCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China; Pathology Department, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China.
Jianfeng XuCenter for Cancer Genomics, Wake Forest University, School of Medicine, Winston-Salem, North Carolina, United States of America; Center for Genetic Epidemiology, Van Andel Research Institute, Grand Rapids, Michigan, United States of America.
Zengnan MoInstitute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, PR China; Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China.
Haiying ZhangCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, PR China; School of Public Health, Guangxi Medical University, Nanning, Guangxi, PR China; General Practice School, Guangxi Medical University, Nanning, Guangxi, China.
Guangxi Medical University · CNFirst Affiliated Hospital of GuangXi Medical University · CNWake Forest University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Only a small proportion of genetic variation in serum ferritin has been explained by variant genetic studies, and genome-wide association study (GWAS) for serum ferritin has not been investigated widely in Chinese population. We aimed at exploring the novel genetic susceptibility to serum ferritin, and performed this two stage GWAS in a healthy Chinese population of 3,495 men aged 20-69 y, including 1,999 unrelated subjects in the first stage and 1,496 independent individuals in the second stage. Serum ferritin was measured with electrochemiluminescence immunoassay, and DNA samples were collected for genotyping. A total of 1,940,243 SNPs were tested by using multivariate linear regression analysis. After adjusting for population stratification, age and BMI, the rs5742933 located in the 5'UTR region of PMS1 gene on chromosome 2 was the most significantly associated with ferritin concentrations (P-combined  = 2.329×10(-10)) (β  =  -0.11, 95% CI: -0.14, -0.07). Moreover, this marker was about 200 kb away from the candidate gene SLC40A1 which is responsible for iron export. PMS1 gene was the novel genetic susceptibility to serum ferritin in Chinese males and its relation to SLC40A1 needs further study.

Indexed as

5' Untranslated RegionsPolymorphism, Single NucleotideQuantitative Trait LociAdultAgedAge FactorsAsian PeopleBiomarkersBody Mass IndexCation Transport ProteinsChromosomes, Human, Pair 2FemaleFerritinsFerroportinGene ExpressionGenome-Wide Association Study5' Untranslated RegionsBiomarkersCation Transport ProteinsFerritinsFerroportinMutL ProteinsNeoplasm ProteinsPMS1 protein, human

Identifiers

PMID25162662
PMCPMC4146590
OpenAlexW2090604157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.